- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Budding.
Displaying page 1 of 1.
EudraCT Number: 2018-001269-18 | Sponsor Protocol Number: VMT-VT-1161-CL-011 | Start Date*: 2019-03-13 | |||||||||||
Sponsor Name:Mycovia Pharmaceuticals, Inc | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the Treatment of Subjects with Recurrent Vulvovaginal Candidiasis | |||||||||||||
Medical condition: Recurrent Vulvovaginal Candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: BG (Completed) PL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001270-26 | Sponsor Protocol Number: VMT-VT-1161-CL-012 | Start Date*: 2018-12-12 | |||||||||||
Sponsor Name:Mycovia Pharmaceuticals, Inc | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VT-1161 Oral Capsules in the Treatment of Subjects with Recurrent Vulvovaginal Candidiasis | |||||||||||||
Medical condition: Recurrent Vulvovaginal Candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001328-17 | Sponsor Protocol Number: IMIB-HTF-2021-01 | Start Date*: 2021-09-23 |
Sponsor Name:Fundación para la formación e investigación sanitarias de la Región de Murcia | ||
Full Title: Histological and clinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1. | ||
Medical condition: Colorectal cancer and triple negative breast cancer patients (TNBC) who shown overexpression of fascin1 in the diagnostic biopsy tissue. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000925-27 | Sponsor Protocol Number: ProF-001_Phase_IIb/III | Start Date*: 2019-08-27 | |||||||||||
Sponsor Name:Profem GmbH | |||||||||||||
Full Title: A phase IIb/III, parallel-arm, randomized, active-controlled, double-blind, double-dummy, study in patients with recurrent vulvovaginal candidiasis to compare the clinical efficacy, safety and tole... | |||||||||||||
Medical condition: recurrent vulvovaginal candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004268-21 | Sponsor Protocol Number: ProF-001_Phase_IIa | Start Date*: 2017-03-23 | |||||||||||
Sponsor Name:Profem GmbH | |||||||||||||
Full Title: A phase IIa randomized, active-controlled, double-blind, dose-escalation study in patients with vulvovaginal candidiasis to evaluate clinical efficacy, safety and tolerability and dose response rel... | |||||||||||||
Medical condition: Vulvovaginal candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004492-12 | Sponsor Protocol Number: SCY-078-306 | Start Date*: 2019-06-05 | |||||||||||
Sponsor Name:SCYNEXIS, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects with Acute Vulvovaginal Candid... | |||||||||||||
Medical condition: Acute Vulvovaginal Candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003147-22 | Sponsor Protocol Number: GLBR-101-2011 | Start Date*: 2011-12-02 | |||||||||||
Sponsor Name:Glenmark Farmaceutica LTDA | |||||||||||||
Full Title: A Multicenter, Open-Label, Comparator-Controlled, Parallel Group, Phase 3 Study to Assess the Efficacy and Safety of Clotrimazole/Clindamycin (200 mg/100 mg FDC) Ovules Compared with Metronidazole ... | |||||||||||||
Medical condition: vaginitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016655-21 | Sponsor Protocol Number: P-090756-01 | Start Date*: 2010-04-30 | |||||||||||
Sponsor Name:Ferrer Internacional, S.A | |||||||||||||
Full Title: A Multi-Centre, Randomized, Placebo-controlled, Parallel-Group, Double-Blinded Study to Compare the Therapeutic Efficacy, Safety and Tolerability of 3 Single Vaginal Doses of Arasertaconazole Nitra... | |||||||||||||
Medical condition: Vulvovaginal Candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) FR (Completed) LT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001201-75 | Sponsor Protocol Number: FHP-2021-2-26 | Start Date*: 2021-09-13 |
Sponsor Name:Female Healthcare Purna | ||
Full Title: A Phase 2, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Miconazole Nitrate 2% + Domiphen Bromide Vaginal cream in the Treatment of Subjects with Acute Vu... | ||
Medical condition: acute vulvovaginal candidiasis | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002600-40 | Sponsor Protocol Number: SCY-078-304 | Start Date*: 2020-01-17 | |||||||||||
Sponsor Name:SCYNEXIS, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) Compared to Placebo in Subjects with Recurrent Vulvova... | |||||||||||||
Medical condition: Recurrent Vulvovaginal Candidiasis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007659-15 | Sponsor Protocol Number: NC-07-03 | Start Date*: 2008-04-22 | ||||||||||||||||||||||||||
Sponsor Name:Lumavita AG | ||||||||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Investigate the Efficacy, Safety, and Tolerability of 3 doses of SPK 0602 (pentamycin) Vaginal Tablets vs Placebo (veh... | ||||||||||||||||||||||||||||
Medical condition: Symptomatic Vaginitis due to Bacterial Vaginosis, Candidiasis or Trichomoniasis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: EE (Completed) DE (Completed) HU (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
